Approvals/NMPA/Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅲ)

Approved

化学药品

Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅲ)

齐鲁制药有限公司🇨🇳 National Medical Products Administration

Approval Id: 8h9obnPsjGG
Approval Number: 国药准字H20253378
Generic Name: 达格列净二甲双胍缓释片(Ⅲ)
Generic Name En: Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅲ)
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 每片含达格列净5mg（按C₂₁H₂₅ClO₆计）和盐酸二甲双胍1000mg
Reg Date: 2025-02-11
Company Name: 齐鲁制药有限公司
Company Address: 山东省济南市高新区新泺大街317号
Production Company Name: 齐鲁制药有限公司
Production Company Address: 山东省济南市高新区旅游路8888号
Company Detail Path: /organization/qi-lu-zhi-yao-you-xian-gong-si
Production Company Detail Path: /organization/qi-lu-zhi-yao-you-xian-gong-si

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Feb 11, 2025

Approval ID

8h9obnPsjGG

Type

化学药品